Ignite Creation Date:
2024-05-05 @ 10:17 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005970
Status:
COMPLETED
Last Update Posted:
2020-08-14
First Post:
2000-07-05
Brief Title:
Doxorubicin Hydrochloride Cyclophosphamide and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2000-05-19
Start Date Type:
ACTUAL
Primary Completion Date:
2005-04-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-01-27
Completion Date Type:
ACTUAL
First Submit Date:
2000-07-05
First Submit QC Date:
January 26 2003
Study First Post Date:
2003-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-13
Last Update Post Date:
2020-08-14
Last Update Post Date Type:
ACTUAL